Get the Stockscreener App
7.50
1.57%
-0.12
Sophia Genetics Sa stock is traded at $7.50, with a volume of 193.28K.
It is down -1.57% in the last 24 hours and up +32.04% over the past month.
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
See More
Previous Close:
$7.62
Open:
$7.7
24h Volume:
193.28K
Relative Volume:
0.65
Market Cap:
$638.46M
Revenue:
$81.18M
Net Income/Loss:
$-80.94M
P/E Ratio:
-6.3511
EPS:
-1.1809
Net Cash Flow:
$-55.15M
1W Performance:
-2.72%
1M Performance:
+32.04%
6M Performance:
+58.23%
1Y Performance:
+128.66%
1-Day Range:
$7.40
$7.70
1-Week Range:
$7.37
$7.88
52-Week Range:
$3.10
$7.88
Sophia Genetics Sa Stock (SOPH) Company Profile
Name
Sophia Genetics Sa
Sector
Industry
Phone
-
Address
-
Compare SOPH vs VEEV, BTSG, TEM, HQY, TXG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOPH
Sophia Genetics Sa
|
7.50 | 644.42M | 81.18M | -80.94M | -55.15M | -1.1809 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Initiated | Craig Hallum | Buy |
| Aug-07-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-27-24 | Initiated | Guggenheim | Buy |
| Nov-29-23 | Initiated | RBC Capital Mkts | Outperform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| Jan-03-23 | Initiated | BTIG Research | Buy |
| Nov-23-22 | Initiated | Credit Suisse | Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-17-21 | Initiated | Cowen | Outperform |
| Aug-17-21 | Initiated | Credit Suisse | Outperform |
| Aug-17-21 | Initiated | JP Morgan | Overweight |
| Aug-17-21 | Initiated | Morgan Stanley | Overweight |
View All
Sophia Genetics Sa Stock (SOPH) Latest News
SOPHiA GENETICS (NASDAQ:SOPH) Insider Philippe Menu Sells 5,000 Shares - MarketBeat
Insider Selling: SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 4,000 Shares of Stock - MarketBeat
SOPHiA GENETICS (SOPH) Q2 2026 Earnings Call Transcript - AOL.com
Sophia Genetics (SOPH) Executive Chairman Jurgi Camblong Sells 2 - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Reaches New 52-Week HighTime to Buy? - MarketBeat
Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
Abhimanyu Verma Sells 5,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells 20,000 Shares - MarketBeat
Sei Investments Co. Buys Shares of 357,888 SOPHiA GENETICS SA $SOPH - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells $123,930.00 in Stock - MarketBeat
SOPH (NASDAQ: SOPH) insider schedules 22,000-share sale under 10b5-1 plan - Stock Titan
SOPHiA GENETICS (SOPH) insider plans Rule 144 sale after 10b5-1 trades - Stock Titan
Sophia Genetics CSO Zhenyu Xu disposes of USD 170,872 in common shares - Bitget
SOPHiA GENETICS Q3 EPS Estimate Lowered by HC Wainwright - MarketBeat
Three Swiss biotechs widen their reach into pharma, paediatrics and lung disease - Startupticker.ch
SOPHiA GENETICS (NASDAQ:SOPH) Insider Sells 3,000 Shares - MarketBeat
HC Wainwright Predicts Reduced Earnings for SOPHiA GENETICS - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Insider Zhenyu Xu Sells 10,000 Shares - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Chairman Sells $138,400.00 in Stock - MarketBeat
BTIG raises Sophia Genetics stock price target on CDx deals By Investing.com - Investing.com South Africa
SOPHiA GENETICS (NASDAQ:SOPH) Hits New 52-Week High After Analyst Upgrade - MarketBeat
SOPH Stock Price and Chart — NASDAQ:SOPH - tradingview.com
BTIG Research Issues Positive Forecast for SOPHiA GENETICS (NASDAQ:SOPH) Stock Price - MarketBeat
SOPHiA GENETICS (NASDAQ:SOPH) Stock Price Expected to Rise, HC Wainwright Analyst Says - MarketBeat
SOPHiA GENETICS Updates Investors With Q2 2026 Form 6-K Filing - The Globe and Mail
BTIG raises Sophia Genetics stock price target on CDx deals - Investing.com
SOPHiA GENETICS partners with AstraZeneca for oncology diagnostics - Yahoo Finance
SOPHiA GENETICS (SOPH) Stock Jumps On Faster Growth And Higher Outlook - Sahm
SOPHiA GENETICS (NASDAQ:SOPH) Shares Up 10.5%Here's Why - MarketBeat
Jurgi Camblong (SOPH) plans 20,000-share sale and details 10b5-1 trades - Stock Titan
SOPHiA GENETICS (SOPH) insider Zhenyu Xu plans 10,000-share stock sale - Stock Titan
Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ... - Yahoo! Finance Canada
SOPHiA GENETICS Q2 Earnings Call Highlights - MarketBeat
Sophia Genetics SA and AstraZeneca Enter Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies - marketscreener.com
SOPH: Q2 revenue up 27% year-over-year, guidance raised, and major biopharma wins secured - TradingView
Earnings call transcript: SOPHiA GENETICS tops revenue estimates in Q2 2026 - Investing.com
SOPH Looks 11.8% Overvalued on GF Value™ - GuruFocus
SOPHiA GENETICS (NASDAQ:SOPH) Issues Quarterly Earnings Results - MarketBeat
Sophia Genetics SA reports results for the quarter ended June 30Earnings Summary - TradingView
SOPH: Q2 2026 revenue rose 27% YoY, with strong U.S. and Liquid Biopsy growth and improved EBITDA loss - TradingView
BRIEF-SOPHiA GENETICS SA Q2 Revenue USD 23.3 Million - TradingView
SOPHiA GENETICS Reports Second Quarter 2026 Results - PR Newswire
Sophia Genetics SA (SOPH) (Q2 2026) Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
H.C. Wainwright reiterates Sophia Genetics stock rating ahead of results - Investing.com
H.C. Wainwright reiterates Sophia Genetics stock rating ahead of results By Investing.com - Investing.com South Africa
Jurgi Camblong Sells 20,000 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock - MarketBeat
SOPHiA GENETICS (SOPH) Expected to Post Earnings on Tuesday - MarketBeat
SOPHiA Genetics CMO Philippe Menu Sells 5,000 Shares via Rule 10b5-1 Trading Plan on July 27, 2026 - Kalkine Media
Sophia Genetics SA (SOPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sophia Genetics SA (SOPH) Cash Flow - TradingKey
Sophia Genetics SA (SOPH) Institutional Confidence - TradingKey
Sophia Genetics Sa Stock (SOPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
6.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):